Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$44.9M
-10.1% from 2023
Prescriptions
2,187
$20,547.38 per claim
Patients
328
348 prescribers
Total spending, 2024
$44.9M
$137,003.39 per patient
Medicare prescription drug plans paid $44.9M for Inrebic in 2024, for 2,187 prescriptions and refills to 328 patients (down 10.1% from 2023). The average cost per claim was $20,547.38.
California had the highest Medicare cost for Inrebic in 2024: $8.5M for 448 claims, followed by Florida ($3.8M).
Catriona Jamieson, hematology-oncology in San Diego, CA, had the highest Medicare cost for Inrebic in 2024: 248 claims costing $4.8M.
Inrebic is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as Celgene/BMS.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Catriona Jamieson San Diego, CA | Hematology-Oncology | 248 | 27 | $4.8M |
| Elizabeth D Weiland Charleston, SC | Nurse Practitioner | 30 | Under 11 | $538K |
| Xiantuo Wu |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 495 | 2,672 | 489 | $52.1M |
| 2023 | 452 | 2,410 | 421 | $50.0M |
| 2024 | 348 | 2,187 | 328 | $44.9M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 17 |
| Under 11 |
| $385K |
| Christine M Barnett Portland, OR | Internal Medicine | 18 | Under 11 | $383K |
| Tri T Vu Houston, TX | Hematology-Oncology | 14 | Under 11 | $379K |
| Ryan J Mattison Madison, WI | Hematopoietic Cell Transplantation and Cellular Therapy | 14 | Under 11 | $373K |
| Kristal Madden Encino, CA | Physician Assistant | 14 | Under 11 | $369K |
| Lisa Law Roseville, CA | Hematology-Oncology | 39 | Under 11 | $361K |
| Jeremy Deutsch Wichita, KS | Hematology-Oncology | 12 | Under 11 | $355K |
| Bart L Scott Seattle, WA | Medical Oncology | 15 | Under 11 | $354K |
| Firas El Chaer Miami, FL | Hematology-Oncology | 13 | Under 11 | $345K |
| Nashat Gabrail Canton, OH | Hematology-Oncology | 13 | Under 11 | $344K |
| Andrew T Chen Bend, OR | Hematology-Oncology | 13 | Under 11 | $343K |
| Anna Koget Pittsburgh, PA | Hematology-Oncology | 13 | Under 11 | $340K |
| Thomas M Cosgriff Metairie, LA | Hematology-Oncology | 13 | Under 11 | $339K |
| Mariette Austin Easton, PA | Hematology-Oncology | 13 | Under 11 | $336K |
| Yuval Raizen Houston, TX | Hematology-Oncology | 12 | Under 11 | $326K |
| Mark B Jennings Allen, TX | Hematology-Oncology | 12 | Under 11 | $325K |
| Robert Legare Providence, RI | Hematology-Oncology | 12 | Under 11 | $323K |
| Elizabeth A Griffiths Buffalo, NY | Hematology-Oncology | 12 | Under 11 | $322K |
| Andrew P Dalovisio Baton Rouge, LA | Hematology-Oncology | 13 | Under 11 | $321K |
| Ayodele G Ayoola Hershey, PA | Hematology-Oncology | 12 | Under 11 | $319K |
| Matthew R Sullivan Claremont, NH | Internal Medicine | 12 | Under 11 | $319K |
| Steven W Yates Henderson, NV | Medical Oncology | 12 | Under 11 | $319K |
| Raymond M Esper Fort Myers, FL | Hematology-Oncology | 12 | Under 11 | $319K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Celgene/BMS BMY | 2,187 | $44.9M |